Cat.#: ASSD-125
Description | Selective fluorescent D1 dopamine receptor antagonist (apparent KD values are 7.09, < 5 and 7.56 for D1, D2 and D5 receptors respectively). Also antagonizes the activity of SKF 83566, a D1 dopamine receptor agonist. Displays no intrinsic agonist activity. |
Size | 50 μg |
Applications | For imaging at the D1 receptor use solutions up to 100 nM. |
Molecule Weight | 877 |
Purity | >97% |
Solubility | Soluble in DMSO |
Excitation | 488 nm |
Emission | 525/550 nm |
Storage | Store at -20° C |
Shipping | Shipped at 4°C |
Important | We strongly recommend storing this product away from light and briefly sonicating the sample when using to ensure it is fully dissolved and the solution is homogeneous. However, we do not recommend using the product after subjecting it to repetitive freeze-thaw cycles. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-193 | N-(Aminoethyl)-5-naphthylamine-1-sulfonic Acid (AC193) | 1 g | inquiry |
ASSD-208 | NBD-X, succinimidyl ester (AC208) | 100 mg | inquiry |
ASSD-184 | BTA-1 (AC184) | 10 mg | inquiry |
ASSD-173 | FITC-Dextran 70 (AC173) | 100 mg, 500 mg | inquiry |
ASSD-222 | Antifade Fluorescence Mounting Medium with Propidium Iodide (hard set) (AC222) | 10 mL | inquiry |
ASSD-202 | 5(6)-Carboxytetramethylrhodamine (AC202) | 100 mg, 250 mg | inquiry |
ASSD-213 | Fluorescein 6-Maleimide (AC213) | 25 mg, 250 mg | inquiry |
ASSD-103 | DAPI Staining Solution (1mg/mL) (AC103) | 1 mL, 5 mL, | inquiry |
ASSD-113 | Thionin acetate salt (AC113) | 5 g | inquiry |
ASSD-132 | Congo Red (AC132) | 100 mg, 1g | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.